Multiple mitochondrial dysfunctions syndrome type 5 is a rare inherited condition that usually starts before birth or in early infancy. It affects how the body makes energy, so babies often have serious signs such as weak muscle tone, feeding problems, developmental delay, seizures, and liver or brain disease. Multiple mitochondrial dysfunctions syndrome type 5 is lifelong, and it is often severe in the first months or years of life. Not everyone will have the same experience, but many affected children become critically ill and the condition can be life-threatening. Treatment does not cure Multiple mitochondrial dysfunctions syndrome type 5, so care focuses on supportive treatment such as nutrition support, seizure control, and close monitoring in specialist care.
How many people live with Multiple mitochondrial dysfunctions syndrome type 5?
Multiple mitochondrial dysfunctions syndrome type 5 is so rare that no reliable estimate of how many people are living with it worldwide or in the United States is regularly published. Rare-disease sources such as Orphanet and the NIH Genetic and Rare Diseases Information Center describe it as ultra-rare, but they do not provide a firm global or U.S. total (Orphanet, 2024; NIH Genetic and Rare Diseases Information Center, 2025).
Overview
Multiple mitochondrial dysfunctions syndrome type 5Symptoms
Multiple mitochondrial dysfunctions syndrome type 5 usually starts in infancy. Main features include severe developmental delay, weak muscle tone, feeding trouble, seizures, and lactic acidosis. Many affected babies also have poor growth and breathing problems.
Outlook and prognosis
Multiple mitochondrial dysfunctions syndrome type 5 usually begins very early and is often severe, with major effects on brain development, muscle tone, feeding, and breathing. Many affected infants have a shortened life expectancy, though the course can vary.
Causes and risk factors
Multiple mitochondrial dysfunctions syndrome type 5 is caused by harmful changes in the ISCA2 gene, usually inherited when both parents pass on a nonworking copy. Risk is higher with a family history or related parents.
Genetic influences
Genetics are central to Multiple mitochondrial dysfunctions syndrome type 5. It is caused by harmful changes in a specific gene, and the exact variant can help confirm the diagnosis and support family testing.
Diagnosis
Multiple mitochondrial dysfunctions syndrome type 5 is usually suspected from clinical features and imaging findings, then confirmed with genetic tests. The diagnosis of Multiple mitochondrial dysfunctions syndrome type 5 may also include blood tests to look for signs of mitochondrial disease.
Treatment and drugs
Treatment for Multiple mitochondrial dysfunctions syndrome type 5 focuses on daily support, such as seizure medicines, feeding help, and breathing care. Some children also receive physical therapy and careful nutrition support. Care is usually guided by a metabolic or mitochondrial disease team.
Symptoms
Multiple mitochondrial dysfunctions syndrome type 5 usually becomes noticeable in infancy, often when a baby is not gaining skills as expected or seems unusually floppy. Early features of Multiple mitochondrial dysfunctions syndrome type 5 can include feeding trouble, seizures, weak muscle tone, and delayed development. Some children also develop stiffness, vision problems, or episodes of low energy as the brain and muscles are affected most. Although features can vary, this is generally a serious condition that needs specialist care.
Babies often reach milestones much later than expected, such as holding up the head, sitting, or making sounds. Over time, learning, movement, and communication are usually severely affected.
Many babies feel unusually floppy and may have trouble supporting the head or moving against gravity. This can make everyday tasks like feeding, carrying, and positioning much harder.
Seizures are common and can begin in infancy, sometimes as staring spells, jerking movements, or whole-body stiffening. They can happen more than once and usually need urgent medical assessment and ongoing treatment.
Sucking and swallowing may be difficult, so feeds can take a long time or wear a baby out quickly. Poor feeding can lead to slow weight gain and worries about growth.
How people usually first notice Multiple mitochondrial dysfunctions syndrome type 5?
The first signs of multiple mitochondrial dysfunctions syndrome type 5 are usually noticed in early infancy, when a baby may seem unusually floppy, feed poorly, gain weight slowly, or miss early milestones such as holding up the head or making steady progress with movement. As how multiple mitochondrial dysfunctions syndrome type 5 is first noticed becomes clearer, families and doctors often see developmental slowing or loss of skills along with vision problems, unusual eye movements, seizures, or breathing and muscle weakness that seem out of proportion to a typical illness. Because this is a rare inherited mitochondrial condition, the early pattern is often recognized through a mix of these symptoms, the baby’s exam, brain imaging, and genetic testing rather than from one single warning sign.
Types of Multiple mitochondrial dysfunctions syndrome type 5
No distinct types of Multiple mitochondrial dysfunctions syndrome type 5 are widely recognized.
Can I slow down the onset of symptoms?
For Multiple mitochondrial dysfunctions syndrome type 5, there is no good evidence that lifestyle changes or current medicines can meaningfully delay when symptoms start. This is a very rare inherited condition caused by a gene change that is present from birth, so factors like diet, exercise, sleep, or supplements have not been shown to reduce the chance of symptoms starting or prevent the condition, although early care from an experienced specialist team can help find and treat problems sooner. Research is still ongoing, and supportive care may help with comfort and daily health, but it cannot guarantee a later onset.
What genetics can tell you about symptoms
In multiple mitochondrial dysfunctions syndrome type 5, genetics can tell you quite a bit: disease-causing changes in the ISCA1 gene are known to cause a very severe form of mitochondrial disease that usually begins in early infancy, often with poor muscle tone, feeding problems, developmental delay, seizures, and signs that the brain is under strain. The exact mix of symptoms and how quickly they worsen can still vary from one child to another, even with changes in the same gene, but overall the genetic finding strongly points to early onset and serious neurological symptoms. Because this condition is so rare, genetics helps most with confirming the diagnosis and giving a general sense of the usual pattern, rather than predicting every symptom with certainty.
Causes and risk factors
Multiple mitochondrial dysfunctions syndrome type 5 is caused by harmful changes in the ISCA1 gene. A child usually develops this condition only when both copies of that gene are affected, and one changed copy is inherited from each parent. The main risk factors are a family history, carrier parents, or parents who are related by blood, because this raises the chance of inheriting the same rare gene change from both sides. No lifestyle, diet, or routine environmental exposure is known to cause Multiple mitochondrial dysfunctions syndrome type 5, but the exact symptoms can vary with the specific gene change and overall health. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Multiple mitochondrial dysfunctions syndrome type 5 is almost always caused by harmful changes in a gene called ISCA1, which keeps the body’s cells from making energy the way they should. The main risk factor is inheriting two changed copies of this gene, one from each biological parent, so the chance is higher when both parents carry the change, when there is a family history, or when the parents are blood relatives. There are no known lifestyle or environmental causes, and it is not caused by anything a parent did or did not do during pregnancy.
Environmental and biological risk factors
Multiple mitochondrial dysfunctions syndrome type 5 is so rare that researchers have not found clear environmental or non-genetic biological risk factors for it. At this time, published evidence does not point to infections, pollution, medications, diet, or pregnancy-related exposures as proven causes. For many families, this means there may be no outside trigger to identify or avoid.
Researchers have not identified any confirmed environmental exposures or non-genetic biological factors that increase the chance of Multiple mitochondrial dysfunctions syndrome type 5. Because the condition is extremely rare, most published reports focus on diagnosis rather than on preventable or body-based risk factors.
Genetic risk factors
Most cases of Multiple mitochondrial dysfunctions syndrome type 5 happen when a child inherits harmful changes in both copies of the ISCA1 gene, one from each parent. For families asking about the genetic causes of Multiple mitochondrial dysfunctions syndrome type 5, ISCA1 is the main gene linked to this condition. Carrying a genetic change doesn’t guarantee the condition will appear, because people with one altered copy are usually healthy carriers. A family history of the condition or known carrier status can raise the chance in future pregnancies.
ISCA1 changes: Harmful changes in the ISCA1 gene are the direct genetic cause of this syndrome. When both copies are not working properly, mitochondria cannot support normal energy production as they should.
Autosomal recessive: Multiple mitochondrial dysfunctions syndrome type 5 is inherited in an autosomal recessive pattern. This means a child must inherit one altered ISCA1 copy from each parent to have the condition.
Carrier parents: People with one altered ISCA1 copy usually do not develop the syndrome and may never know they are carriers. If both parents are carriers, each pregnancy has a 1 in 4 chance of the child having the condition, a 1 in 2 chance of the child being a carrier, and a 1 in 4 chance of inheriting no altered copy.
Family history: If there is already a child or close relative with Multiple mitochondrial dysfunctions syndrome type 5, other relatives may also carry the same gene change. This can matter when family members are planning a pregnancy or considering genetic testing.
Related parents: Parents who are biologically related are more likely to carry the same rare ISCA1 change from a shared ancestor. This can increase the chance of rare recessive conditions, including Multiple mitochondrial dysfunctions syndrome type 5.
Lifestyle risk factors
Multiple mitochondrial dysfunctions syndrome type 5 is not caused by lifestyle habits, but daily routines can still influence energy balance, symptom burden, and the risk of metabolic stress. In practice, how lifestyle affects Multiple mitochondrial dysfunctions syndrome type 5 is mostly about avoiding strain on already fragile mitochondrial function and supporting nutrition, comfort, and safety. Because this condition is usually severe and medically complex, lifestyle changes should be individualized with the treating metabolic or neurology team.
Long gaps without food can increase metabolic stress in people with Multiple mitochondrial dysfunctions syndrome type 5. Regular meals or prescribed feeds may help reduce low-energy states and support more stable day-to-day function.
Poor intake can worsen weakness, poor growth, and recovery because cells already have trouble producing energy efficiently. A nutrition plan that provides adequate calories, protein, and any clinician-recommended supplements can support overall stability.
Dehydration can make fatigue, irritability, and metabolic strain worse in mitochondrial disease. Steady fluid intake, especially during hot weather or minor illness, may help lower the risk of decompensation.
Overexertion can trigger excessive fatigue or symptom worsening when mitochondrial energy production is impaired. Gentle, paced movement or physical therapy may help preserve comfort, joint mobility, and function without pushing beyond tolerance.
Risk prevention
Multiple mitochondrial dysfunctions syndrome type 5 is a rare inherited condition, so there is no proven way to prevent the condition itself if the gene change is already present. For many living with Multiple mitochondrial dysfunctions syndrome type 5, prevention is mainly about lowering the chance of complications, supporting growth and development, and avoiding extra stress on the body. Prevention is flexible—it adapts to your life and health background. Because this condition can affect the brain, muscles, and energy use, care is usually individualized with a specialist team.
If Multiple mitochondrial dysfunctions syndrome type 5 runs in a family, genetic counseling can help clarify recurrence risk before pregnancy or when planning a family. This may include carrier testing for relatives and a discussion of reproductive options.
Ongoing care with metabolic, neurology, and pediatric specialists can help catch problems early before they become more serious. This is often the best way to reduce complications from Multiple mitochondrial dysfunctions syndrome type 5 over time.
Infections can put extra strain on a body that already has trouble making energy, so routine vaccines, hand hygiene, and early medical attention for fever can help. Prevention works best when combined with regular check-ups.
Good nutrition and steady hydration may help reduce metabolic stress, especially during illness or periods of poor feeding. Some children with Multiple mitochondrial dysfunctions syndrome type 5 need a feeding plan tailored to their growth and swallowing needs.
Can you prevent Multiple mitochondrial dysfunctions syndrome type 5?
No, this condition cannot be prevented with diet, exercise, medicines, or other lifestyle changes because it is caused by inherited gene changes that are present from the start. For families with a known history of multiple mitochondrial dysfunctions syndrome type 5, genetic counseling and carrier testing before or during pregnancy may help clarify the risk and discuss reproductive options, but they cannot change the gene changes in someone who already has the condition.
Transmission
Multiple mitochondrial dysfunctions syndrome type 5 is not infectious, so it cannot be passed from one person to another through coughing, touch, sex, food, or everyday contact. Instead, the genetic transmission of Multiple mitochondrial dysfunctions syndrome type 5 usually happens when a child inherits two nonworking copies of the related gene, one from each parent.
For many families asking how Multiple mitochondrial dysfunctions syndrome type 5 is inherited, the usual pattern is autosomal recessive inheritance: both parents are healthy carriers, and in each pregnancy there is a 1 in 4, or 25%, chance the child will have the condition. This means Multiple mitochondrial dysfunctions syndrome type 5 is very rare and does not spread through communities the way an infection does.
When to test your genes
Consider genetic testing if a baby or child has unexplained low muscle tone, developmental delay, seizures, high lactic acid, or liver or breathing problems, especially with a family history of a mitochondrial disorder. Testing can confirm MMDS5, help guide monitoring and supportive care, and inform family planning.
Diagnosis
Multiple mitochondrial dysfunctions syndrome type 5 is usually suspected when a baby or young child has serious nerve-related symptoms, such as feeding problems, low muscle tone, delayed development, or seizures, especially when these changes appear early and progress quickly. Getting a diagnosis is often a turning point toward answers and support. Doctors combine the child’s clinical features with brain imaging, lab findings, and genetic tests to confirm the diagnosis of Multiple mitochondrial dysfunctions syndrome type 5.
Doctors look closely at the pattern of symptoms, especially early developmental problems, weak muscle tone, movement difficulties, seizures, and vision changes. In Multiple mitochondrial dysfunctions syndrome type 5, this combination can raise concern for a mitochondrial disease affecting the brain and nerves.
Imaging often shows changes in the brain’s white matter and other signs of injury in areas that help control movement and development. These imaging findings can support the genetic diagnosis of Multiple mitochondrial dysfunctions syndrome type 5 when they match the child’s symptoms.
Blood and sometimes urine tests may show signs that the body is not making energy normally, such as elevated lactate or related metabolic changes. These results are not specific on their own, but they help doctors look for mitochondrial disorders and rule out other causes.
A gene panel, exome test, or other genetic test can look for disease-causing changes linked to this syndrome. Finding harmful changes in both copies of the related gene is usually the key step in confirming the diagnosis.
How is Multiple mitochondrial dysfunctions syndrome type 5 diagnosed?
Doctors usually suspect multiple mitochondrial dysfunctions syndrome type 5 from a pattern of very early symptoms, often in infancy, such as low muscle tone, seizures, delays in development, feeding problems, and changes on a brain scan, along with blood or urine tests that may show the body is under stress and not making energy normally, such as a high lactic acid level. Because these signs can look like other serious disorders, the diagnosis is usually confirmed with genetic testing to find the disease-causing change in the related gene. In some cases, doctors may also do extra lab tests, and sometimes a muscle test, to support the diagnosis and rule out similar conditions.
Stages of Multiple mitochondrial dysfunctions syndrome type 5
Multiple mitochondrial dysfunctions syndrome type 5 does not have defined progression stages. This is because it is a rare inherited condition that is identified by its pattern of symptoms and test results, rather than by a standard step-by-step decline that doctors divide into stages. Doctors usually start with a conversation about when problems first appeared, such as low muscle tone, feeding trouble, developmental delay, or seizures, and the early symptoms of Multiple mitochondrial dysfunctions syndrome type 5 can vary from one child to another. Diagnosis and follow-up usually involve physical exams, blood tests, brain imaging, and genetic testing to confirm the cause and help guide care over time.
Outlook and prognosis
The outlook for multiple mitochondrial dysfunctions syndrome type 5 is generally poor, because it usually presents in infancy with severe neurologic impairment, feeding difficulties, and progressive multisystem disease. Most affected children have profound developmental delay and do not achieve independent motor milestones, and many require ongoing nutritional and respiratory support. Seizures, spasticity, vision problems, and recurrent infections can further worsen quality of life and clinical stability over time. Mortality is high in the most severe cases, with death often occurring in infancy or early childhood from respiratory failure, metabolic decompensation, or other complications of advanced mitochondrial disease. Prognosis may vary somewhat depending on the specific genetic change and the severity of organ involvement, but long-term survival into later childhood or adulthood appears to be uncommon. Current care is mainly supportive, so early multidisciplinary management may improve comfort and reduce complications, but it does not usually change the underlying progressive course.
Long-term effects
Many living with Multiple mitochondrial dysfunctions syndrome type 5 can face serious health effects from early infancy, often affecting growth, movement, and the brain. Long-term effects vary widely, but the condition is usually severe and can limit development across many body systems. For families, this can mean a child who has ongoing feeding trouble, low energy, and delayed milestones rather than steadily gaining new skills on the usual timeline.
Children with this condition often have marked delays in sitting, standing, speaking, and other developmental milestones. In more severe cases, development remains very limited over time.
Low muscle tone and weakness can affect head control, movement, and daily activities as a child grows. Some may also develop poor coordination or increased stiffness later on.
Seizures, abnormal brain development, and progressive injury to brain tissue can shape long-term outcomes. Early symptoms of Multiple mitochondrial dysfunctions syndrome type 5 often include neurologic problems that continue to affect learning and function.
Trouble feeding, poor weight gain, and slow growth are common long-term features. Some children also have repeated vomiting or difficulty swallowing.
How is it to live with Multiple mitochondrial dysfunctions syndrome type 5?
Living with multiple mitochondrial dysfunctions syndrome type 5 often means daily life is shaped by severe energy failure in the body, especially in the brain and muscles, so many living with this condition have major developmental challenges and may need help with feeding, movement, breathing, and communication. Because it usually begins in infancy or early childhood and can worsen over time, routines often revolve around therapies, specialist visits, medications, and close monitoring for neurologic problems such as seizures, muscle stiffness, or loss of skills.
For families and other caregivers, the condition can change nearly every part of daily life, from sleep and work schedules to emotional stress and the need for hands-on care throughout the day and night. Even so, supportive care, rehabilitation services, and practical adaptations at home can help people with this condition be more comfortable and help families build steadier, more manageable routines.
Treatment and drugs
Multiple mitochondrial dysfunctions syndrome type 5 is usually treated with supportive care, because there is no cure that can fix the underlying genetic problem at this time. Treatment often looks different for each person, but it commonly focuses on day-to-day needs such as seizure control, help with feeding and nutrition, breathing support, physical therapy, and careful management during infections or other illnesses. Some children may need medicines to reduce seizures, a feeding tube if eating is not safe or enough, or hospital care during flare-ups, and the best approach depends on which symptoms are most severe. Because this condition can affect several organs and can change over time, care is often coordinated by a team that may include neurology, metabolic, lung, heart, nutrition, and therapy specialists.
Can you cure Multiple mitochondrial dysfunctions syndrome type 5?
No, there is currently no cure for Multiple mitochondrial dysfunctions syndrome type 5. Treatment focuses on supportive care, which means managing problems as they come up, such as seizures, feeding difficulties, breathing problems, and delays in movement or development. These treatments can help with comfort, safety, and day-to-day care, but they cannot remove the underlying genetic cause.
Non-drug treatment
Living with Multiple mitochondrial dysfunctions syndrome type 5 often affects feeding, movement, breathing, and development in daily life, so care usually centers on comfort, safety, and function. Managing this condition often means working with several specialists to support the body systems that are most affected. There is no proven non-drug treatment that fixes the underlying gene problem, but supportive care for Multiple mitochondrial dysfunctions syndrome type 5 can still improve day-to-day well-being. The exact mix of therapies depends on age, symptoms, and how severely the condition is affecting energy use in the body.
Feeding support can help when low muscle tone, tiredness, or poor swallowing makes it hard to take in enough calories. Some children need high-calorie meal plans, tube feeding, or a gastrostomy tube for safer, steadier nutrition.
Speech and swallow therapy can lower the risk of choking and help with safer eating and drinking. Therapists may suggest changes in food texture, pacing, and positioning during meals.
Physical therapy can help protect joint movement, reduce stiffness, and support comfort when weakness limits everyday activity. For many, this can mean guided stretching, gentle strengthening, and help with positioning or transfers.
Occupational therapy focuses on daily tasks such as seating, hand use, and easier ways to interact with the environment. Adaptive equipment may help with comfort, posture, and participation at home.
Your genes may have an impact on how drugs work for you
In multiple mitochondrial dysfunctions syndrome type 5, the genetic change mainly affects how the body makes energy, and there are not well-established gene-based rules that tell doctors which medicines will work best for this condition. Many living with this disorder may still respond differently to medicines used for related problems, such as seizures or movement symptoms, so treatment is usually adjusted carefully based on what helps, what causes side effects, and whether problems like liver disease or severe weakness are present. In day-to-day life, this can mean one child may do fairly well on a seizure medicine while another becomes more sleepy or more weak, which is why close follow-up matters and why doctors are often careful to avoid medicines that can put extra stress on mitochondria, the parts of cells that make energy.
Pharmacological treatments
For many living with Multiple mitochondrial dysfunctions syndrome type 5, drug treatment is mainly about easing symptoms such as seizures, muscle stiffness, reflux, or breathing-related discomfort, because there is no proven medicine that corrects the underlying energy problem. Care is usually individualized and may change over time as symptoms change. Not everyone responds to the same medication in the same way.
Anti-seizure drugs such as levetiracetam, clobazam, or topiramate may be used if Multiple mitochondrial dysfunctions syndrome type 5 causes seizures. The best choice depends on seizure type, age, and side effects.
Baclofen or diazepam may help reduce muscle stiffness, spasms, or painful tightness. For some children, easing spasticity can make positioning, dressing, and daily care a little easier.
Drugs such as omeprazole or lansoprazole may be prescribed for acid reflux, which can add to feeding problems and irritability. In some children, these medicines may reduce vomiting, back-arching, or discomfort after feeds.
Polyethylene glycol and lactulose are often used when low muscle tone, limited movement, or feeding issues lead to constipation. Softer, more regular stools can improve comfort and appetite.
Genetic influences
Multiple mitochondrial dysfunctions syndrome type 5 is a genetic condition caused by disease-causing changes in both copies of the ISCA1 gene. This gene helps mitochondria, the parts of cells that make energy, build tiny iron-sulfur parts that many proteins need in order to work, so when ISCA1 is not working properly, several body systems can be affected. It is inherited in an autosomal recessive pattern, which means a child develops the condition only after inheriting one nonworking copy of ISCA1 from each parent. A carrier means you hold the gene change but may not show symptoms. When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with multiple mitochondrial dysfunctions syndrome type 5, a 50% chance of a carrier child, and a 25% chance of a child who inherits neither altered copy. Knowing how multiple mitochondrial dysfunctions syndrome type 5 is inherited can help families understand recurrence risk, consider testing for relatives, and talk through future pregnancy options with a genetics specialist.
Is Multiple mitochondrial dysfunctions syndrome type 5 genetic?
Genetics are central to Multiple mitochondrial dysfunctions syndrome type 5. It is caused by harmful changes in a specific gene, and the exact variant can help confirm the diagnosis and support family testing.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a part. In some situations, though, one well-studied variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Because this condition is caused by an inherited gene change that disrupts how cells make energy, the genetic result matters a great deal when treatment is being planned. At this time, there is no approved drug that corrects the underlying cause of Multiple mitochondrial dysfunctions syndrome type 5, so care is mainly supportive and tailored to symptoms such as seizures, low muscle tone, feeding problems, or breathing trouble. Beyond trial and error, genetics offers another way to confirm the diagnosis, guide day-to-day care, and help families understand why usual treatments often cannot change the course of the disease. The gene finding can also help doctors use medicines more cautiously, since people with severe mitochondrial disease may be more sensitive to side effects, especially when a drug puts extra strain on the brain, muscles, or liver. In practice, treatment options for Multiple mitochondrial dysfunctions syndrome type 5 often focus on careful symptom control, nutrition support, physical therapy, and close monitoring rather than one medicine that reverses the condition. Genetic testing may also help families reach specialist teams, consider research studies, and get counseling about future pregnancies.
Interactions with other conditions
People living with Multiple mitochondrial dysfunctions syndrome type 5 often have problems in several body systems at once, so other illnesses can place extra strain on the brain, muscles, breathing, and overall energy levels. Even a common infection such as the flu or pneumonia can make weakness, feeding trouble, or seizures worse, and some may find recovery takes longer than expected. Doctors call it a “comorbidity” when two conditions occur together. In Multiple mitochondrial dysfunctions syndrome type 5, lung disease, swallowing problems with choking or aspiration, and severe malnutrition can interact with the underlying mitochondrial disorder and raise the risk of hospital stays. Seizure disorders can also be harder to manage if another illness causes dehydration, fever, or low blood sugar, and the early symptoms of Multiple mitochondrial dysfunctions syndrome type 5 may overlap with other serious neurologic or metabolic conditions. Because this condition is rare and often severe, coordinated care is important so treatments for one problem do not unintentionally worsen another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Multiple mitochondrial dysfunctions syndrome type 5?
Because multiple mitochondrial dysfunctions syndrome type 5 can cause things like delayed development, seizures, low muscle tone, weakness, and serious illness early in life, it can be mistaken for other mitochondrial diseases, other inherited conditions that make it hard for the body to turn food into energy, and some seizure or muscle disorders. In some children, doctors also need to rule out cerebral palsy, damage from lack of oxygen around birth, severe infections, or other brain conditions that affect movement and learning. Doctors usually tell these apart by looking at the pattern of symptoms over time and using blood tests, brain scans, and genetic testing.
History
Families usually begin looking for answers after a baby or young child has serious health problems that seem to affect several parts of the body at once. With multiple mitochondrial dysfunctions syndrome type 5, that search can feel especially confusing because the condition is very rare, and its early signs can overlap with other severe metabolic or neurologic disorders.
The condition came into view gradually through careful reports of infants and children with similar patterns of illness, including poor muscle tone, feeding problems, developmental difficulties, and signs that the body was struggling to make energy normally. Not every early description was complete, yet together they helped doctors recognize that these children were not simply experiencing unrelated symptoms. As medical testing improved, researchers were better able to connect the brain, muscle, and blood chemistry findings into a single syndrome.
Building on this early work, scientists later showed that multiple mitochondrial dysfunctions syndrome type 5 belongs to a small group of inherited conditions that disrupt how cells handle energy and certain key chemical processes. That mattered because it moved the condition from being described only by what doctors could see to being understood at a deeper biological level. In recent years, this has helped make diagnosis more precise, especially when clinicians are investigating the early symptoms of multiple mitochondrial dysfunctions syndrome type 5 in a very sick newborn or infant.
Even so, much of the history of this condition is still recent, because only a limited number of affected families have been described in the medical literature. For many living with multiple mitochondrial dysfunctions syndrome type 5 and their families, that can mean fewer long-term studies and less public awareness than for better-known disorders. Still, each carefully documented case has added to what doctors know today and has helped improve recognition, testing, and support.